findmyKOL
Clinical trialNCT05148949UnknownPhase 4Interventional

Study on Three Doses of an Inactivated COVID-19 Vaccine in Chinese Pulmonary Tuberculosis Patients

SponsorJiangsu Province Centers for Disease Control and PreventionEnrollment240COVID-19Pulmonary Tuberculosis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Jing-Xin Li, PhD

    Jiangsu Provincial Center for Diseases Control and Prevention

    Principal Investigator
  • Li-mei Zhu

    Jiangsu Provincial Center for Diseases Control and Prevention

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Huai'An No.4 People'S Hospital

    Huai'an, Jiangsu, China

    Recruiting
  • Taizhou People'S Hospital

    Taizhou, Jiangsu, China

    Recruiting
  • Wuxi No.5 People'S Hospital

    Wuxi, Jiangsu, China

    Recruiting
  • Xuzhou Infectious Disease Hospital

    Xuzhou, Jiangsu, China

    Jing-Xin Li, PhD
    Recruiting
  • Binhai County Hospital of Chinese Medicine

    Yancheng, Jiangsu, China

    Recruiting
  • Danyang Center for Disease Control and Prevention

    Zhenjiang, Jiangsu, China

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
22 Dec 2021
Primary completion
10 Dec 2022
Completion
10 Mar 2023
Last update posted
16 Aug 2022
Registered enrollment
240
Registry id
NCT05148949

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.